在移植中定制塔克罗利斯剂量:专注于药物遗传学
Nuria Lloberas1, Anna Vidal-Alabró1, Helena Colom2
1Nephrology Department, Hospital Universitari de Bellvitge-Institut d'Investigació Biomèdica de Bellvitge (IDIBELL); and.
Therapeutic drug monitoring
|January 8, 2025
概括
药物遗传学显著影响移植患者的塔克罗利斯药物水平. 将遗传数据集成到人群药动力学模型中,可以个性化剂量,改善治疗目标的实现,减少变异性.
科学领域:
- 药理学 药理学是指药理学的学科.
- 遗传学 是一个遗传学.
- 移植医学 移植医学
背景情况:
- 塔克罗利穆斯的药理动力学受到药物代谢酶和转运体的遗传变异的影响.
- CYP3A4和CYP3A5基因多态性对塔克罗利斯剂量至关重要,影响患者的暴露.
- 塔克罗利斯药理动学的患者间的变化需要个性化的剂量策略.
研究的目的:
- 审查包括药物遗传学在塔克罗利斯剂量调整中的人口药物动力学研究.
- 检查将这些模型转化为移植的临床实践.
- 突出药物遗传学在个性化塔克罗利斯治疗中的作用.
主要方法:
- 对塔克罗利斯的种群药动力学模型的当前文献的综述.
- 对将药物遗传数据整合到剂量算法中的研究进行分析.
- 对验证个性化塔克罗利斯剂量方法的临床试验的评估.
主要成果:
- 纳入药物遗传学的种群药物动力学模型可以改善塔克罗利斯剂量个性化.
- 这些模型有助于最大限度地减少塔克罗利斯的暴露不足和过度暴露,从而增加目标的实现.
- 临床试验证明了在移植中以药物遗传学为指导剂量的有效性.
结论:
- 药物遗传学是管理移植受体中塔克罗利莫斯暴露变异性的关键因素.
- 将药物遗传数据整合到人口药物动力学模型中,有助于在移植中实现个性化医疗.
- 这些方法的临床应用得到了验证,对于优化塔克罗利斯治疗至关重要.
相关概念视频
01:11Renal Failure: Dose Adjustments
62
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
62
01:15Drug Dosage Regimen: Overview
3.4K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
3.4K
01:15Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
41
Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
41
01:31Factors Affecting Renal Clearance: Drug's Physicochemical Properties and Plasma Levels
167
Renal clearance of a drug is influenced by various factors, including its physicochemical properties and plasma levels. These factors play a significant role in determining how efficiently the kidneys eliminate a drug.
One important factor is the drug's molecular size. The kidneys readily excrete smaller molecules below 300 Daltons (Da). On the other hand, molecules weighing between 300 and 500 Da are excreted through both urine and bile. Larger molecules above 500 Da tend to be excreted...
One important factor is the drug's molecular size. The kidneys readily excrete smaller molecules below 300 Daltons (Da). On the other hand, molecules weighing between 300 and 500 Da are excreted through both urine and bile. Larger molecules above 500 Da tend to be excreted...
167
01:20Chronopharmacokinetics: Time-Dependent Pharmacokinetics
83
Chronopharmacokinetics studies the temporal change in drug absorption and elimination. These changes can be cyclical or non-cyclical. Cyclical changes occur over a regular interval, while non-cyclical changes occur over a longer, irregular period.
Time-dependent pharmacokinetics refers to non-cyclical changes in drug rate processes over a period of time. It can lead to nonlinear pharmacokinetics, where the relationship between drug concentration and time is not proportional. Non-cyclical...
Time-dependent pharmacokinetics refers to non-cyclical changes in drug rate processes over a period of time. It can lead to nonlinear pharmacokinetics, where the relationship between drug concentration and time is not proportional. Non-cyclical...
83
01:19Nonlinear Pharmacokinetics: Overview
264
Nonlinear or dose-dependent pharmacokinetics is a phenomenon that occurs when the pharmacokinetic parameters of certain drugs deviate from linear pharmacokinetics at higher doses. These drugs do not follow the expected first-order kinetics, where the rate of drug elimination is directly proportional to the drug concentration. Instead, they exhibit a nonlinear relationship, which can be attributed to several factors.
Nonlinearity can arise due to the saturation of plasma protein-binding or...
Nonlinearity can arise due to the saturation of plasma protein-binding or...
264